2022 annual financial data
Valion Bio 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was -484.73%.
Operating income was -10,098,000 USD and net income was -10,096,000 USD.
Operating cash flow was -8,919,000 USD.
Get free Valion Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,840,000 USD
- Operating income
- -10,098,000 USD
- Net income
- -10,096,000 USD
- Operating cash flow
- -8,919,000 USD